COVID-19 Cancer-Related Resources

The COVID-19 global pandemic is affecting people around the world and is of great concern to many cancer patients. In addition to information about the virus and how to protect ourselves, kidney cancer patients need information about cancer treatment, follow-up care and other cancer-specific details about managing our health during the pandemic.

While the local situation and individual risk of each cancer patient differs, there is a universal need for credible and reliable information. On this page, IKCC has curated information from trusted, evidence-based sources about COVID-19, as well as cancer-specific resources.

If your organisation has information to be included, please contact Julia Black at info@ikcc.org. 

The impact of COVID-19 on the kidney cancer community

This report highlights the impact of the COVID-19 pandemic on the kidney cancer community. The report covers the impact the pandemic has had on patients, their lifestyle and mental health; the impact on cancer patient organisations; the effect on cancer research; and the influence on kidney cancer diagnosis and treatments.

Download the report here: The impact of COVID-19 on the kidney cancer community

COVID-19 vaccines and kidney cancer patients

Vaccination against COVID using approved COVID-19 vaccines has been shown to be effective and safe. There is a small risk of developing an allergic reaction to the vaccine, and discussion of these risks needs to occur with your doctor prior to receiving the vaccine.

There is no clear evidence that the vaccine will be less effective, or side effects to the vaccine will be worsened by receiving either targeted drugs or immune therapy typically administered to patients with kidney cancer, nor is having kidney cancer a reason to avoid the vaccine.

The IKCC Medical Advisory Board believes that the benefits of being vaccinated against COVID strongly outweigh the risks of the vaccines themselves. Ultimately, this is a decision you need to make in conjunction with your doctor.

Guidance on the COVID-19 vaccine for patients with cancer participating in oncology clinical trials can be found here: https://www.nature.com/articles/s41571-021-00487-z

International Organisations and Societies:

 

	The Impact of COVID-19 on Cancer Patient Organisations COVID-19: Impact on Cancer Patient Organisations Worldwide in 2020 (Part 2) GCCN’s first Coalition Connection event examined the effects of COVID-19 and the innovative strategies patient advocacy organisations have employed in the wake of this global health crisis. Watch the recording here. Global Alliance Joint Statement on COVID-19
	ASCO: American Society of Clinical Oncology
	ESMO: European Society of Medical Oncology Cancer Care during the COVID-19 Pandemic: An ESMO Guide of Patients ESMO Webinar Series: SARS-CoV-2 Vaccination: Special Considerations in Patients with Cancer
	UICC: Union for International Cancer Control
	WHO: World Health Organization

Information and guidance by country:

 

Australia		Australian Government Department of Health
Brazil		Ministry of Health Pan American Health Organisation COVID e Cancer de Rim Infomed Consent And Algorithm COVID 19
Canada		Government of Canada
France		Government of France
Germany		Federal Ministry of Health Cancer Information Service
India		Indian Council of Medical Research
Japan		Japanese Cancer Society
Netherlands		National Institute of Public Health Government
Spain		Spanish Society of Cancer Spanish Group of Genitourinary tumors
Sweden		Government Offices of Sweden Government Health
UK		Government of the UK National Health Service (NHS) National Institute for Health and Care Excellence ( N I C E ) Cancer Research UK
USA		NIH National Cancer Institute US Food & Drug Administration FDA American Cancer Society

Videos/Podcasts

 

A Podcast by The Uromigos
Discussing COVID-19 and Renal Cell Carcinoma Episode 10

 

 

 

VHL in the COVID Era:
Management Approaches and Modifications

Fonte: IKCC